Abiopharma

🔍 Walsh Mark T. (Director)

Company: Savers Value Village, Inc. (SVV)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Acquired 50,000 shares of Common Stock at $1.41 per share (Direct)
  Date: 2026-08-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 97,363.00 | transaction_form_type: 4
• Acquired 50,000 shares of Common Stock at $3.16 per share (Direct)
  Date: 2026-08-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 147,363.00 | transaction_form_type: 4
• Sold 100,000 shares of Common Stock at $12.2036 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 47,363.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 42,059 shares of Common Stock at $1.41 per share (Direct)
  Date: 2026-08-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 89,422.00 | transaction_form_type: 4
• Acquired 50,000 shares of Common Stock at $3.16 per share (Direct)
  Date: 2026-08-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 139,422.00 | transaction_form_type: 4
• Sold 92,059 shares of Common Stock at $11.9261 per share (Direct)
  Date: 2026-08-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 47,363.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 50,000 shares of Stock Options (Right to Purchase) at $1.41 per share (Derivative)
  Date: 2026-08-10 | Code: M | Expires: 2029-10-07 | equity_swap_involved: 0 | shares_owned_after: 582,859.00 | transaction_form_type: 4 | Footnotes: F4, F5, F6
• Sold 50,000 shares of Stock Options (Right to Purchase) at $3.16 per share (Derivative)
  Date: 2026-08-10 | Code: M | Expires: 2030-12-09 | equity_swap_involved: 0 | shares_owned_after: 710,395.00 | transaction_form_type: 4 | Footnotes: F4, F7, F6
• Sold 42,059 shares of Stock Options (Right to Purchase) at $1.41 per share (Derivative)
  Date: 2026-08-11 | Code: M | Expires: 2029-10-07 | equity_swap_involved: 0 | shares_owned_after: 540,800.00 | transaction_form_type: 4 | Footnotes: F4, F5, F6
• Sold 50,000 shares of Stock Options (Right to Purchase) at $3.16 per share (Derivative)
  Date: 2026-08-11 | Code: M | Expires: 2030-12-09 | equity_swap_involved: 0 | shares_owned_after: 660,395.00 | transaction_form_type: 4 | Footnotes: F4, F7, F6

Footnotes:

• F1: The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026.
• F2: This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $11.74 to $12.41. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
• F3: This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $11.72 to $12.15. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
• F4: Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions.
• F5: The October 7, 2019 stock option grant vested in substantially equal annual installments over five years starting October 7, 2020, and was fully vested on October 7, 2024.
• F6: The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately.
• F7: The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025.